New Key Statistics Module, Z-Score and F-Score
FRA:NIH Key Ratios
Market Cap € M | 2,530.89 |
Enterprise Value € M | 2,794.56 |
P/E(ttm) | 40.25 |
PE Ratio without NRI | 40.25 |
Forward PE Ratio | 15.76 |
Price/Book | 4.16 |
Price/Sales | 5.40 |
Price/Free Cash Flow | 24.67 |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) € M | 450.00 |
EPS (TTM) € | 0.11 |
Beneish M-Score | -2.45 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | 6.90 |
y-y EBITDA Growth Rate % | 5.80 |
EV-to-EBIT | 29.20 |
EV-to-EBITDA | 16.80 |
PEG | 5.83 |
Shares Outstanding M | 533.85 |
Net Margin (%) | 13.40 |
Operating Margin % | 22.73 |
Pre-tax Margin (%) | 16.12 |
Quick Ratio | 1.05 |
Current Ratio | 1.05 |
ROA % (ttm) | 3.76 |
ROE % (ttm) | 10.64 |
ROIC % (ttm) | 8.51 |
Dividend Yield % | -- |
Altman Z-Score | 3.45 |
FRA:NIH Number of Guru Trades
FRA:NIH Volume of Guru Trades
Gurus Latest Trades with FRA:NIH
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
FRA:NIH is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data